Clinical Trial Update: A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial evaluating AAV2-hAADC gene therapy for Aromatic L-amino Acid Decarboxylase (AADC) deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aromatic L-amino Acid Decarboxylase Deficiency

Drugs mentioned

• AAV2-hAADC (AAV2-hAADC)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Aromatic L-amino Acid Decarboxylase (AADC) Deficiency | Phase 1, Phase 2 | Status: COMPLETED